Biodegradable Core-Shell Carriers for Simultaneous Encapsulation of Synergistic Actives

被引:165
作者
Windbergs, Maike [1 ,4 ,5 ,6 ]
Zhao, Yuanjin [1 ,7 ]
Heyman, John [1 ,8 ]
Weitz, David A. [1 ,2 ,3 ]
机构
[1] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA
[2] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA
[3] Harvard Univ, Kavli Inst Bionano Sci & Technol, Cambridge, MA 02138 USA
[4] Univ Saarland, Dept Biopharmaceut & Pharmaceut Technol, D-66119 Saarbrucken, Germany
[5] Helmholtz Inst Pharmaceut Sci Saarland, Saarbrucken, Germany
[6] Korea Inst Sci & Technol, Ctr BioMicrosyst, Seoul, South Korea
[7] Southeast Univ, State Key Lab Bioelect, Seoul 210096, South Korea
[8] Habsel Inc, Cambridge, MA 02142 USA
关键词
MONODISPERSE DOUBLE EMULSIONS; ORAL DELIVERY; DRUGS; MICROCAPSULES; GENERATION; THERAPY; BREAKUP; DEVICE; CELLS;
D O I
10.1021/ja401422r
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Simultaneous encapsulation of multiple active substances in a single carrier is essential for therapeutic applications of synergistic combinations of drugs. However, traditional carrier systems often lack efficient encapsulation and release of incorporated substances, particularly when combinations of drugs must be released in concentrations of a prescribed ratio. We present a novel biodegradable core shell carrier system fabricated in a one-step, solvent-free process on a microfluidic chip; a hydrophilic active (doxorubicin hydrochloride) is encapsulated in the aqueous core, while a hydrophobic active (paclitaxel) is encapsulated in the solid shell. Particle size and composition can be precisely controlled, and core and shell can be individually loaded with very high efficiency. Drug-loaded particles can be dried and stored as a powder. We demonstrate the efficacy of this system through the simultaneous encapsulation and controlled release of two synergistic anticancer drugs using two cancer-derived value for encapsulation of other active cell lines. This solvent-free platform technology is also of high potential ingredients and chemical reagents.
引用
收藏
页码:7933 / 7937
页数:5
相关论文
共 32 条
  • [1] Drug delivery systems: Entering the mainstream
    Allen, TM
    Cullis, PR
    [J]. SCIENCE, 2004, 303 (5665) : 1818 - 1822
  • [2] Residual solvent testing: A review of gas-chromatographic and alternative techniques
    B'Hymer, C
    [J]. PHARMACEUTICAL RESEARCH, 2003, 20 (03) : 337 - 344
  • [3] Structure of multiresponsive "intelligent" core-shell microgels
    Berndt, I
    Pedersen, JS
    Richtering, W
    [J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2005, 127 (26) : 9372 - 9373
  • [4] pH-Sensitive degradable polymersomes for triggered release of anticancer drugs: A comparative study with micelles
    Chen, Wei
    Meng, Fenghua
    Cheng, Ru
    Zhong, Zhiyuan
    [J]. JOURNAL OF CONTROLLED RELEASE, 2010, 142 (01) : 40 - 46
  • [5] Study of SPG membrane emulsification processes for the preparation of monodisperse core-shell microcapsules
    Chu, LY
    Xie, R
    Zhu, JH
    Chen, WM
    Yamaguchi, T
    Nakao, S
    [J]. JOURNAL OF COLLOID AND INTERFACE SCIENCE, 2003, 265 (01) : 187 - 196
  • [6] Dendukuri D., 2009, Adv. Mater, V21, P1
  • [7] Double emulsions - Scope, limitations and new achievements
    Garti, N
    [J]. COLLOIDS AND SURFACES A-PHYSICOCHEMICAL AND ENGINEERING ASPECTS, 1997, 123 : 233 - 246
  • [8] Biocompatibility and erosion behavior of implants made of triglycerides and blends with cholesterol and phospholipids
    Guse, C.
    Koennings, S.
    Maschke, A.
    Hacker, M.
    Becker, C.
    Schreiner, S.
    Blunk, T.
    Spruss, T.
    Goepferich, A.
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2006, 314 (02) : 153 - 160
  • [9] Humberstone AJ, 1997, ADV DRUG DELIVER REV, V25, P103, DOI 10.1016/S0169-409X(96)00494-2
  • [10] Mechanisms of drug combinations: interaction and network perspectives
    Jia, Jia
    Zhu, Feng
    Ma, Xiaohua
    Cao, Zhiwei W.
    Li, Yixue X.
    Chen, Yu Zong
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2009, 8 (02) : 111 - 128